Hormone Therapy Safe For Postmenopausal BRCA Mutation Carriers According To Observational Study
Sep 30th 2008Drug InformationEndocrinology
The use of hormone therapy was associated with a reduced risk of breast cancer in postmenopausal women who carry BRCA mutations, according to a case-control study published online September 23 in the Journal of the National Cancer Institute. Women who carry a mutation in the BRCA1 gene may opt to have their ovaries removed to lower their risk of developing breast cancer.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
